<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lex H</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>University of Michigan</funding><funding>NCATS NIH HHS</funding><funding>Depression Center, University of Michigan</funding><funding>NIMH NIH HHS</funding><funding>A. Alfred Taubman Medical Research Institute</funding><funding>National Institute of Mental Health</funding><pagination>135-139</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8628522</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>291</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Electroconvulsive therapy (ECT) is highly effective for treatment-resistant depression (TRD), and previous studies have demonstrated short-term improvements in quality of life (QoL) after ECT.  However, long-term QoL after ECT has not been studied, and the baseline patient characteristics that predict long-term QoL remain unknown.&lt;h4>Methods&lt;/h4>Seventy-nine subjects with unipolar or bipolar TRD were enrolled in this prospective longitudinal observational study. Physical, psychological, social, and environmental QoL domains were measured with the abbreviated World Health Organization Quality of Life scale (WHOQOL-BREF) at baseline and every 6 months for up to 2 years after ECT.  Baseline sociodemographic and clinical features were tested for association with long-term Qo</pubmed_abstract><journal>Journal of affective disorders</journal><pubmed_title>Long-term quality of life in treatment-resistant depression after electroconvulsive therapy.</pubmed_title><pmcid>PMC8628522</pmcid><funding_grant_id>K23 MH092648</funding_grant_id><funding_grant_id>K23 MH 092648</funding_grant_id><funding_grant_id>UL1 TR000433</funding_grant_id><funding_grant_id>2UL1 TR 000433</funding_grant_id><funding_grant_id>UL1 TR002538</funding_grant_id><pubmed_authors>Jensen EL</pubmed_authors><pubmed_authors>Ginsburg Y</pubmed_authors><pubmed_authors>Mickey BJ</pubmed_authors><pubmed_authors>Lex H</pubmed_authors><pubmed_authors>Nevers SW</pubmed_authors><pubmed_authors>Maixner DF</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long-term quality of life in treatment-resistant depression after electroconvulsive therapy.</name><description>&lt;h4>Background&lt;/h4>Electroconvulsive therapy (ECT) is highly effective for treatment-resistant depression (TRD), and previous studies have demonstrated short-term improvements in quality of life (QoL) after ECT.  However, long-term QoL after ECT has not been studied, and the baseline patient characteristics that predict long-term QoL remain unknown.&lt;h4>Methods&lt;/h4>Seventy-nine subjects with unipolar or bipolar TRD were enrolled in this prospective longitudinal observational study. Physical, psychological, social, and environmental QoL domains were measured with the abbreviated World Health Organization Quality of Life scale (WHOQOL-BREF) at baseline and every 6 months for up to 2 years after ECT.  Baseline sociodemographic and clinical features were tested for association with long-term Qo</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2025-04-26T16:34:28.883Z</modification><creation>2025-04-06T15:13:01.913Z</creation></dates><accession>S-EPMC8628522</accession><cross_references><pubmed>34038830</pubmed><doi>10.1016/j.jad.2021.05.012</doi></cross_references></HashMap>